Web
Analytics
The news is by your side.

Lynparza

EU approves drug for pancreatic cancer

Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate among the most common cancers.1 Approximately 5-7% of patients with metastatic pancreatic cancer have a germline BRCA mutation.